CurvaFix Showcases Pioneering CurvaFix® IM Implant for Pelvic Trauma Fracture Repair at AAOS 2022 Annual Meeting

2022-10-02 01:04:35 By : Mr. ZDAN Shanghai

Novel, Implantable Device Designed to Enable Simpler, Minimally Invasive Surgery and Stronger Fixation

BELLEVUE, Wash., March 22, 2022--(BUSINESS WIRE)--CurvaFix, Inc., a developer of medical devices to repair fractures in curved bones, announced today that it will showcase the new CurvaFix® IM Implant at the American Academy of Orthopaedic Surgeon’s (AAOS) 2022 Annual Meeting in Chicago. In addition to showcasing the novel CurvaFix Implant in its booth (#3669), the company will provide updates from recent U.S. cases using the CurvaFix Implant for fixation of pelvic and acetabular fractures.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220322005270/en/

The CurvaFix® IM Implant is the only intramedullary device capable of following the complex curvature and filling the intramedullary space within the bony structures of the pelvis, enabling a longer, wider, and curved implant to provide strong fracture fixation. (Photo: Business Wire)

"The patients we have treated using the new CurvaFix Implant have tolerated their surgeries well," said Samir Mehta, M.D., chief of the Division of Orthopaedic Trauma and Fracture Care and associate professor in Orthopaedic Surgery. "The CurvaFix Implant has tremendous versatility allowing surgeons to follow the natural shape of the bone, filling the cancellous space, and achieving a stable construct. Most recently, we treated a 70-year-old female metastatic cancer patient with a bilateral sacral fragility fracture resulting in chronic pain and disability. We were able to provide effective fixation of her dysmorphic upper sacral segment using two CurvaFix Implants placed trans-iliac trans-sacral with the patient being able to walk out of the hospital the same day."

The CurvaFix Implant is the only implant capable of following natural bone curvature to fill space within the bone, designed to offer a less invasive, shorter surgery for pelvic fracture patients with a quicker recovery. The implant body has interlocking segments that provide flexibility during implantation over a steerable guidewire. After implantation, the surgeon locks the CurvaFix Implant curvature (making the device rigid) by setting the patented Lock.

"Our novel device has been used in multiple market segments including high impact trauma, fragility fractures in geriatric patients, revision surgeries for failed straight screw fixation, and in an oncology patient who suffered a fragility fracture due to cancer treatment," said Steve Dimmer, chief executive officer. "The results thus far are very encouraging, as is our early clinical data.

"The CurvaFix Implant is the only intramedullary device capable of following the natural bone shape and filling the space within the pelvis, enabling a longer, wider and curved implant which provides strong fracture fixation," continued Dimmer. "The strong curved fixation of our device may improve patient recovery, reduce pain and enable earlier mobility compared to traditional surgical techniques."

Pelvic fractures affect more than 165,000 people per year in the U.S,1 caused by car accidents or falls. These fractures are among the most serious and technically complex injuries treated by orthopedic trauma surgeons. Current surgical techniques with straight screws can be limited by bone curvature, and surgery with bone plates can require lengthy, invasive open procedures. Pelvic fragility fractures affect nearly 100,000 people annually in the U.S.2 Pelvic fragility fracture repair can be limited by patient health, weak bone and bone curvature.

CurvaFix, Inc. is a privately held medical device company headquartered in Bellevue, Wash. The idea for the company germinated when the former division head of orthopedic trauma at the University of British Columbia, Clinical Professor Emeritus, Robert Meek, M.D., FRCSC, believed there was a better way to repair pelvic fractures. Today, CurvaFix is developing implantable products to improve fracture repair in curved bones. The company’s first product is the CurvaFix IM Implant, which has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

CurvaFix is a trademark of CurvaFix, Inc., registered in the U.S.

12021 Trauma Update, Orthopedic Network News, Volume 32, No. 2, April 2021 2Orthopedic News Network (ONN), Vol 32, No 2, April 2021

View source version on businesswire.com: https://www.businesswire.com/news/home/20220322005270/en/

Amy Cook Acook@curvafix.com

Leaving these accounts open could tarnish your golden years.

David Trainer, the CEO of the investment research firm New Constructs, believes there are now roughly 300 publicly-traded zombie companies.

The bear market in software stocks has already lasted far longer than the typical decline, according to MoffettNathanson,

September more than lives up to its reputation as an ugly month for stocks. Here's what the data says about October performance.

This has not been a good time for Ford (NYSE: F) stock; its price is down nearly 44% year to date as bad feelings have taken hold among analysts. Ford expects its third-quarter inflation-related supplier costs to run $1 billion higher than expected as a number of high-margin trucks and SUVs, with missing components due to supply shortages. Menawhile, Ford president Jim Farley has reorganized his executive lineup once again.

Inflation, interest rates, and recession – these are the bogeymen of investing, and they’ve been watching over our shoulders for the past several months. We all know the story by now, the rate of inflation is running at generational highs, the Federal Reserve is hiking rates in an attempt to push back against high prices, and that’s likely to tip the economy into recession. At a time like this, investors are showing a growing interest in finding strong defensive portfolio moves. It’s a mindset t

Most retirees end up waiting until what is called their full retirement age (FRA) of 66 or 67, or even later, before claiming Social Security benefits. The goal is to maximize the value of your Social Security benefits into retirement for as long as possible. A helpful exercise can be to figure out how much Social Security you would qualify for at certain ages and annual incomes, which will help you decide on whether to take Social Security early or wait for your FRA.

MarketWatch Picks has highlighted these products and services because we think readers will find them useful; the MarketWatch News staff is not involved in creating this content. Since the start of the year, mortgage rates have been trending upwards — and according to many experts, this trend will likely continue through October. Echoing that sentiment, Kate Wood, home expert at NerdWallet, says interest rates for 30-year fixed-rate loans appear to be staying over 6% and products like the 15-year fixed and the 5-year ARMs are averaging over 5%.

Semiconductor stocks have tumbled in recent months amid flagging demand, with the S&P Semiconductors Select Industry Index dropping 36% year to date. Bank of America analysts recently discussed their favorite choices in the sector.

States are stepping in with financial aid as White House remains silent on new round of federal funding.

(Bloomberg) -- Mohamed El-Erian has a cautionary word for anyone anticipating an end to interest-rate increases from the Federal Reserve and other central banks.Most Read from BloombergMacKenzie Scott Files for Divorce From Science Teacher HusbandMarjorie Taylor Greene’s Husband Files for Divorce After 27 YearsTop Apple Executive Is Leaving After Making Crude Remarks in TikTok VideoMeta to Cut Headcount for First Time, Slash Budgets Across TeamsWalmart, CVS Face Suits Blaming Common Painkiller f

Shares of Annaly Capital Management (NYSE: NLY) were among the losers this week as rising mortgage rates threatened to squeeze the mortgage REIT, and one analyst expressed caution on the stock. The company also executed a reverse stock split at the beginning of the week. Since the rate hike, which came with hawkish commentary from Fed Chair Jerome Powell, investors seem to believe the risk of a recession has grown, as well as the likelihood of a sustained high-interest-rate environment.

The bears are running rampant on Wall Street. Of the 43 analysts surveyed by Refinitiv that cover Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL), 38 of them rate the tech stock as a buy or strong buy. It's not surprising, therefore, that Wall Street's consensus 12-month price target reflects a 47% upside potential.

It didn't see a market for single-player games anymore, according to 9to5 Google.

Stock market investors loathe rising interest rates, but they have upsides — bonds are generating returns again and financial instruments like fixed annuities, with their returns tied to bonds, are up massively. How much? Lifetime fixed-income annuity payouts are up 29% to 30% from a year ago, depending on your gender. Meanwhile, the Dow Jones Industrial Average is down nearly...

Sheryl Sandberg recently stepped down as Meta COO, but the company will continue to pay for her personal security through June 2023.

These top-tier companies are begging to be bought following a 34% peak decline in the Nasdaq Composite.

Amazon is holding a sale on Fire tablets, with the Fire HD 10 back down to its Prime Day price of $75. The newer Fire 7 is down to $45.

Yahoo Finance Live examines Carnival Cruise's stock after its latest earnings miss signifies a much longer path to profitability than expected.

Google will formally reveal the smartwatch and the Pixel 7 lineup on October 6th.